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Advances in voltage-gated calcium channel structure, function and physiologyIt is well established that calcium ions are important signalling
molecules that mediate a wide range of physiological functions,
includingmuscle contraction, enzyme activation, and secretion. Excitable
cells contain numerous pathways bywhich intracellular calcium concen-
tration can be elevated. Voltage-gated calcium channels are the primary
mechanism of depolarization evoked calcium entry into heart, muscle
and brain cells. The mammalian genome expresses multiple calcium
channel subtypes that fulﬁll speciﬁc cellular functions. These calcium
channels can either be monomers (as is the case with low voltage- acti-
vated T-type calcium channels), or multimeric protein complexes that
are formed through the assembly of multiple calcium channels subunits
(as for the high voltage-activated calcium channels). This special issue
of BBA Biomembranes, focuses on some of the key roles of calcium chan-
nels, as well as aspects of calcium channel structure and modulation.
In the lead off article, Dr. Diane Lipscombe discusses the role of al-
ternate splicing in calcium channel function. Most calcium channel
subtypes are subject to regulation by alternate splicing mechanisms,
and the resulting splice variants support speciﬁc cellular functions.
Dr. Jiang Yang then describes the regulation of high voltage-activated
calcium channels by the ancillary Cavβ subunit. This subunit associates
with the pore forming Cavα1 subunit of the channel complex to not
only regulate plasma membrane expression, but also channel function
and modulation. Along these lines, Dr. Annette Dolphin discusses the
role of the othermajor high voltage-activated calcium channel ancillary
subunit – Cavα2δ – in membrane trafﬁcking of the channel complex,
and as a target for the gabapentinoid pain therapeutics. Dr. Jin Tao
then focuses on low voltage activated T-type calcium channels and
their modulation by second messengers. T-type calcium channels
play major roles in network synchrony and epilepsy as discussed
byDrs. Hee-Sup Shin and Snutch in two articles in this issue. In addition,
there is growing evidence that T-type channels mal also control low
threshold exocytosis, as described by Drs. Norbert Weiss and Zamponi.
Dr. Kurt Beam leads off a series of articles concerning the Cav1
(L-type) calcium channel family. Dr. Beam summarizes the unique
functioning of the skeletal muscle Cav1.1L-type channel. Dr. Alexandra
Koschak then discusses how naturally occurring mutation in the Cav1
family provides novel insights into calcium channel structure and func-
tion. Rounding out the L-type channel segment, Dr. Emilio Carbone fo-
cuses on the roles of Cav1.2 and Cav1.3 calcium channels in chromafﬁn
cells. The issue then moves towards N-type (Cav2.2) calcium channels.
Dr. Adams provides a detailed overview ofmodulation of N-type calcium
channels by peptide toxins isolated from ﬁsh hunting cone snails, and
their therapeutic potential for chronic pain. Drs. Kevin Currie and
Zamponi then provide a detailed account concerning the modulation
of N-type calcium channels by G proteins and G protein coupled re-
ceptors, a ﬁeld of long history and an example of deep insights into0005-2736/$ – see front matter © 2013 Elsevier B.V. All rights reserved.
http://dx.doi.org/10.1016/j.bbamem.2013.03.014molecular mechanisms of channel modulation. Dr. Henry Colecraft
takes a broader view of high voltage activated calcium channel modula-
tion by RGKproteins, a family of small G proteins thatmediate a complex
regulation of calcium channel activity. Finally, Dr. Daniela Pietrobon
completes the issue by highlighting the role of Cav2.1 (P/Q-type) calcium
channels in familial forms of migraine. In patients with this disorder
naturally occurring mutations in the P/Q-type gene give rise to migraine
phenotypes with varying degrees of severity.
Clearly, this collection of reviews is only a snapshot of the many
exciting ﬁndings in the calcium channel ﬁeld. However, it provides a
topical overview of pertinent topics in this area by some of the world's
leading calcium channel researchers.Dr. Zamponi is one of the leading experts in the ﬁeld of
voltage gated calcium channels, with a speciﬁc interest in
the role of calcium channels in the development of chronic
pain. Dr. Zamponi has published close to 200 peer reviewed
articles and holds numerous US patents on new pain thera-
peutics. He is an Alberta Innovates-Health Solutions Scientist
and Canada Research Chair, and he is currently the Senior
Associate dean for Research in the Faculty of Medicine at
the University of Calgary.Dr. Snutch is a Professor and Canada Research Chair in the
Michael Smith Laboratories, Departments of Psychiatry
and Zoology, and the Brain Research Centre at the Univer-
sity of British Columbia. He is best known for his seminal
work on the family of voltage-gated calcium channels as
it relates to their molecular cloning, modulation and phar-
macology. Dr. Snutch has also designed and developed
novel small organic calcium channel blockers aimed at
the treatment of pain and epilepsy and which are currently
in human clinical trials.Gerald W. Zamponi⁎
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